Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial

OBJECTIVE: Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump has been available for the past 25 years. CIPII, with its specific pharmacodynamic properties, may be a viable treatment alternative to improve glycemic control in patients with type 1 diabetes for whom other the...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Logtenberg, Susan J., Kleefstra, Nanne, Houweling, Sebastiaan T., Groenier, Klaas H., Gans, Reinold O., van Ballegooie, Evert, Bilo, Henk J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Diabetes Association 2009
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713651/
https://ncbi.nlm.nih.gov/pubmed/19429874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-2340
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg